Re-Taking the Pulse® EU5 Medical Oncology compared to Hematological Oncology will show behavioral differences between the two specialists, and how their channel preferences and digital adoption augmented during the pandemic. The directional country level insights will help better understand how to best utilize digital and offline channels to cater to Oncologists’ needs from different regions
Questions answered in this report:
- How can pharmas differentiate their messaging through curated multichannel tactics during COVID-19?
- How are emerging channels (e.g. voice, telehealth, etc.) reshaping physicians workflow during COVID-19?
- How can pharma boost physician engagement with their personal promotion and online channels as physicians move to remote care, e.g., pharma sales reps, pharma owned HCP websites, and sponsored content on third-party websites and social media?